Загрузка...
Tolerogenic Nanoparticles to Treat Islet Autoimmunity
PURPOSE OF REVIEW: The current standard therapy for type 1 diabetes (T1D) is insulin replacement. Autoimmune diseases are typically treated with broad immunosuppression, but this has multiple disadvantages. Induction of antigen-specific tolerance is preferable. The application of nanomedicine to the...
Сохранить в:
| Опубликовано в: : | Curr Diab Rep |
|---|---|
| Главные авторы: | , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
2017
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5748287/ https://ncbi.nlm.nih.gov/pubmed/28791576 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11892-017-0914-z |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|